7 stories mentioning NHCUpdated 7d ago
Every FINWIRES story that references NHC, newest first.
Josh A McReary, Senior Vice President & General Counsel, on September 10, 2026, sold 2,719 shares in National Healthcare (NHC) for $609,669. Following the Form 4 filing with the SEC, McCreary has control over a total of 9,979 common shares of the company, with 9,979 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1047335/000143774926030334/xslF345X05/rdgdoc.xml
Brian F Kidd, Senior Vice President, CFO, on September 11, 2026, sold 6,813 shares in National Healthcare (NHC) for $1,537,694. Following the Form 4 filing with the SEC, Kidd has control over a total of 23,183 common shares of the company, with 23,183 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1047335/000143774926030323/xslF345X05/rdgdoc.xml
Ben Anderson Flatt Sr, Senior Vice President & Chief Information Officer, on August 12, 2026, sold 7,000 shares in National Healthcare (NHC) for $1,593,000. Following the Form 4 filing with the SEC, Flatt has control over a total of 15,636 common shares of the company, with 15,636 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1047335/000143774926029512/xslF345X05/rdgdoc.xml
Stephen Fowler Flatt, Director, CEO, on August 19, 2026, sold 1,500 shares in National Healthcare (NHC) for $355,620. Following the Form 4 filing with the SEC, Flatt has control over a total of 65,487 common shares of the company, with 65,487 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1047335/000143774926028642/xslF345X05/rdgdoc.xml
Healthcare stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.1% lower and the iShares Biotechnology ETF (IBB) up 1.2%.ANI Pharmaceuticals (ANIP) shares were down nearly 7% even after the company posted higher Q2 adjusted earnings and net revenue.National HealthCare (NHC) stock was up more than 2% after the company reported higher Q2 non-GAAP earnings and net operating revenue.Neurocrine Biosciences (NBIX) shares were up more than 1% after the company said it has started a phase 1 first-in-human trial of NBIP-1968, an experimental drug for obesity.
Emil E Hassan, Director, on June 16, 2026, sold 1,563 shares in National Healthcare (NHC) for $312,561. Following the Form 4 filing with the SEC, Hassan has control over a total of 71,532 common shares of the company, with 71,532 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1047335/000143774926021139/xslF345X05/rdgdoc.xml
Timothy J. Shelly, Senior Vice President, Operations, on May 19, 2026, sold 1,853 shares in National Healthcare (NHC) for $365,444. Following the Form 4 filing with the SEC, Shelly has control over a total of 1,294 common shares of the company, with 1,294 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1047335/000143774926017945/xslF345X05/rdgdoc.xml
